TITLE

Efficacy of a New Autologus Platelet Gel: in Vitro Study

AUTHOR(S)
Tayer, A. Hashemi; Alizadeh, Sh; Bateni, M. Heidari
PUB. DATE
June 2012
SOURCE
Iranian Journal of Pediatric Hematology & Oncology;Jun2012, Vol. 2 Issue 2, p54
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Autologus platelet gel is easy to prepare and is relatively low cost. The aim of this study was to prepare and evaluate in vitro efficacy of autologus platelet gel. Materials and Methods In this experimental study, platelet concentrate and platelet poor plasma were prepared with aphaeresis method. Thrombin was prepared by mixing the plasma with calcium. Thrombin activity level was determined by spectrophotometric method. The platelet gel was obtained by adding thrombin and calcium to the platelet rich plasma. The concentration of growth factors was measured using the enzyme-linked immunosorbent assay technique. Results Platelet rich plasma contained a total average of 1×1011 platelet in the 100 ml product. The highest activity of prepared thrombin was achieved at a ratio of 5 vol (5ml) platelet poor plasma to 1 volium (1ml) calcium gluconate (p=0.02). Produced thrombin was stable for two hours at 24°C, six hours at 4°C, and more than three months at -20°C (p=0.04). Concentration of platelet derived growth factor and transforming growth factors-β in platelet gel supernatants were generally high (23.2 ± 6 ng/ml, 18.2 ± 5ng/ml respectively), whereas epithelial growth factor and fibroblast growth factor were present at low concentration (870 ± 110 pg/ml, 24.7 ± 3 pg/ml respectively). Conclusion With proper production, large numbers of platelets in the platelet rich plasma will be activated, hence high concentration of growth factors will be produced.
ACCESSION #
85927396

 

Related Articles

  • Circulating beta amyloid protein is elevated in patients with acute ischemic stroke. Lee, P. H.; Bang, O. Y.; Hwang, E. M.; Lee, J. S.; Joo, U. S.; Mook-Jung, I.; Huh, K. // Journal of Neural Transmission;Oct2005, Vol. 112 Issue 10, p1371 

    Recent clinical and experimental studies suggest that ischemic strokes may play an important role in the pathogenesis of Alzheimer’s disease (AD). Beta amyloid (Aβ), a major component of senile plaque in AD, is known to be derived from ischemic brain or activated platelets. We...

  • Failure of Thrombin-Antithrombin III Complexes in the Diagnosis of Deep Vein Thrombosis. Cogo, Alberto; Lensing, Anthonie; Prandoni, Paolo; Canova, Giuseppe; de Toni, Renzo; Cuppini, Stefano; Ruol, Arturo // Angiology;Dec1992, Vol. 43 Issue 12, p975 

    Plasma thrombin-antithrombin III (T-AT) complexes are reputed to be an indirect manifestation of thrombin generation, and a role for their determination in the diagnosis of deep vein thrombosis (DVT) has been advocated. In order to evaluate the accuracy of T-AT complexes assay for DVT diagnosis,...

  • Platelet-stored angiogenesis factors: Clinical monitoring is prone to artifacts. Starlinger, Patrick; Alidzanovic, Lejla; Schauer, Dominic; Brugger, Philipp; Sommerfeldt, Silvia; Kuehrer, Irene; Schoppmann, Sebastian F.; Gnant, Michael; Brostjan, Christine // Disease Markers;2011, Vol. 31 Issue 2, p55 

    Background: The analysis of angiogenesis factors in the blood of tumor patients has given diverse results on their prognostic or predictive value. Since mediators of angiogenesis are stored in platelets, their measurement in plasma is sensitive to inadvertent platelet activation during blood...

  • Oxidative Versus Thrombotic Stimulation of Platelets Differentially activates Signalling Pathways. Karimi, Pouran; Rashtchizadeh, Nadereh // Journal of Cardiovascular & Thoracic Research;2013, Vol. 5 Issue 2, p61 

    Introduction: Atherosclerosis is one of the inflammatory underlying disease associated by oxidative stress and thrombotic agents. This study aimed to evaluate the potential role of cupper oxidized low-density lipoprotein (OxLDL) and thrombin for inducing mitogen activated protein kinases (MAPKs)...

  • Stability of thromboxane in blood samples. Helgadóttir, Helga; Ólafsson, Ísleifur; Andersen, Karl; Gizurarson, Sveinbjörn // Vascular Health & Risk Management;Jun2019, Vol. 15, p143 

    Introduction: Conventional venous blood collection requires a puncture with a needle through the endothelium of a vessel. The endothelial injury causes activation of circulating platelets and the release of thromboxane A2. The aim of the study was to investigate if platelets continue to form...

  • Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo. Jochen Graff; Nils von Hentig; Karina Kuczka; Carlo Angioni; Peter Gute; Stefan Klauke; Errol Babacan; Sebastian Harder // Journal of Antimicrobial Chemotherapy (JAC);Feb2008, Vol. 61 Issue 2, p394 

    Objectives In the past, bleeding events have been described for patients with haemophilia taking HIV-1 protease inhibitors. Recently, the FDA published a warning concerning intracranial haemorrhage in patients taking the HIV-1 protease inhibitor tipranavir co-administered with ritonavir. ...

  • Erratum to: A novel ELISA for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers. Lobo, Vivian; Shetty, Shrimati; Kulkarni, Bipin; Butera, Diego; Magalhaes, Geraldo; Ghosh, Kanjaksha // Annals of Hematology;Jul2015, Vol. 94 Issue 7, p1259 

    A correction to the article "A novel ELISA for diagnosis of Glanzmann's thrombasthenia and the heterozygote carriers" by Vivian Lobo, Shrimati Shetty and Bipin Kulkarni, that was published in the previous issue is presented.

  • Cytotoxic evaluation of Melia azedarach in comparison with, Azadirachta indica and its phytochemical investigation. Jafari, Samineh; Saeidnia, Soodabeh; Hajimehdipoor, Homa; Reza Shams Ardekani, Mohammad; Ali Faramarzi, Mohammad; Hadjiakhoondi, Abbas; Khanavi, Mahnaz // DARU;2013, Vol. 21 Issue 5, p1 

    Background: Melia azedarach L. is an important medicinal plant that is used for variety of ailments in Iranian traditional medicine. Azadirachta indica A. Juss is its allied species and possesses similar properties and effects. The present study was undertaken to investigate anticancer activity...

  • The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs. Trevisin M; Neeson P; Savige J // Journal of Clinical Pathology;Mar2004, Vol. 57 Issue 3, p303 

    BACKGROUND: The demonstration of proteinase 3 specific antineutrophil cytoplasmic antibodies (PR3-ANCA), and the estimation of antibody values are useful in the diagnosis and management of patients with Wegener's granulomatosis (WG). However, external quality assessment programmes suggest that...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics